These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7411552)

  • 1. Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.
    Weinstock J; Wilson JW; Ladd DL; Brush CK; Pfeiffer FR; Kuo GY; Holden KG; Yim NC; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM; Ridley PT
    J Med Chem; 1980 Sep; 23(9):973-5. PubMed ID: 7411552
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
    Pfeiffer FR; Wilson JW; Weinstock J; Kuo GY; Chambers PA; Holden KG; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM
    J Med Chem; 1982 Apr; 25(4):352-8. PubMed ID: 7069713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
    Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE
    J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neuroleptics.
    Kaiser C; Ali FE; Bondinell WE; Brenner M; Holden KG; Ku TW; Oh HJ; Ross ST; Yim NC; Zirkle CL; Hahn RA; Sarau HM; Setler PE; Wardell JR
    J Med Chem; 1980 Sep; 23(9):975-6. PubMed ID: 6106062
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
    J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.
    Kaiser C; Dandridge PA; Garvey E; Hahn RA; Sarau HM; Setler PE; Bass LS; Clardy J
    J Med Chem; 1982 Jun; 25(6):697-703. PubMed ID: 6980283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.
    Pettersson I; Gundertofte K; Palm J; Liljefors T
    J Med Chem; 1992 Feb; 35(3):502-7. PubMed ID: 1531365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.
    Baindur N; Tran M; Niznik HB; Guan HC; Seeman P; Neumeyer JL
    J Med Chem; 1992 Jan; 35(1):67-72. PubMed ID: 1531075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs.
    Hahn RA; Wardell JR
    J Cardiovasc Pharmacol; 1980; 2(5):583-93. PubMed ID: 6157951
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzaz epi ne-7, 8-diol. 6-Position modifications.
    Ross ST; Franz RG; Gallagher G; Brenner M; Wilson JW; DeMarinis RM; Hieble JP; Sarau HM
    J Med Chem; 1987 Jan; 30(1):35-40. PubMed ID: 3806602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
    Woodman OL; Rechtman MP; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analogs of SCH 23390 as discriminators of dopamine receptor subtypes: behavioral interactions between D-1 and D-2 agonists and antagonists.
    O'Boyle KM; Molloy AG; Mashurano M; Waddington JL
    Psychopharmacol Bull; 1986; 22(3):599-604. PubMed ID: 2879303
    [No Abstract]   [Full Text] [Related]  

  • 14. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectic effect of SK & F 38393, a new dopamine agonist in rats.
    Girdhar A; Sharma DC; Sachdev KS
    Indian J Physiol Pharmacol; 1982; 26(4):317-20. PubMed ID: 6984016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on renal dopamine receptors with a new agonist.
    Pendleton RG; Samler L; Kaiser C; Ridley PT
    Eur J Pharmacol; 1978 Sep; 51(1):19-28. PubMed ID: 29762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents acting on the central nervous system. X. 1-Substituted 3-phenyl-2,3,4,5-tetrahydro-1H-1-benzazepines.
    Khanna JM; Anand N
    J Med Chem; 1967 Sep; 10(5):944-5. PubMed ID: 6048506
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.
    Pettersson I; Liljefors T; Bøgesø K
    J Med Chem; 1990 Aug; 33(8):2197-204. PubMed ID: 1973733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
    Andersen PH; Nielsen EB; Scheel-Krüger J; Jansen JA; Hohlweg R
    Eur J Pharmacol; 1987 Jun; 137(2-3):291-2. PubMed ID: 2956116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.